|
R3HDM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.607560E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.193800E-04 |
| Normal-vs-Stage2 |
2.828000E-02 |
| Normal-vs-Stage3 |
3.842000E-02 |
| Normal-vs-Stage4 |
1.53160999999402E-05 |
| Stage1-vs-Stage2 |
8.450600E-01 |
| Stage1-vs-Stage3 |
3.036800E-01 |
| Stage1-vs-Stage4 |
7.937700E-03 |
| Stage2-vs-Stage3 |
5.897200E-01 |
| Stage2-vs-Stage4 |
3.017900E-02 |
| Stage3-vs-Stage4 |
1.218270E-03 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.804300E-04 |
| Normal-vs-AfricanAmerican |
1.559900E-02 |
| Normal-vs-Asian |
6.167800E-04 |
| Caucasian-vs-AfricanAmerican |
3.539400E-01 |
| Caucasian-vs-Asian |
3.072600E-01 |
| AfricanAmerican-vs-Asian |
8.750600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.644300E-04 |
| Normal-vs-Female |
5.607100E-04 |
| Male-vs-Female |
2.634800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.567000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.883820E-03 |
| Normal-vs-Age(61-80Yrs) |
7.214100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.413240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.040200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.116400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.168200E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.940200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.039500E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.90239999999476E-05 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.724000E-01 |
| Classical-VS-Follicular |
4.058800E-01 |
| Classical-VS-Other |
3.219000E-01 |
| Classical-VS-Normal |
7.61479999999981E-05 |
| Tall-VS-Follicular |
8.242400E-01 |
| Tall-VS-Other |
2.719000E-01 |
| Tall-VS-Normal |
1.861750E-02 |
| Follicular-VS-Other |
2.554400E-01 |
| Follicular-VS-Normal |
1.257880E-02 |
| Other-VS-Normal |
6.382000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.536000E-02 |
| Normal-vs-N1 |
1.194070E-04 |
| N0-vs-N1 |
8.738200E-03 |
|
|
